Premium
Healthcare-focused private equity firm InvAscent has floated its fourth fund that could push its assets under management closer to the $1-billion mark, three people close to the development told VCCircle. The PE firm, which has backed companies such as General Diagnostics, Gland Pharma, Dr Agarwal's Health Care, and Neuland Labs in the past, ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.